Management Protocols for Type 2 Diabetes
Metformin combined with lifestyle modifications should be the first-line therapy for most adults with type 2 diabetes, with SGLT-2 inhibitors or GLP-1 receptor agonists added for patients with inadequate glycemic control or those with cardiovascular/renal comorbidities. 1
Initial Assessment and Treatment Algorithm
Step 1: Initial Therapy
For most adults with newly diagnosed T2DM:
For patients with specific presentations:
Step 2: Monitoring and Intensification
Monitor HbA1c every 3 months
If treatment goals not met after 3 months, intensify therapy:
Add SGLT-2 inhibitor if patient has:
- Heart failure
- Chronic kidney disease
- High cardiovascular risk
Add GLP-1 receptor agonist if patient has:
- Increased stroke risk
- Weight loss as important goal
- Established atherosclerotic cardiovascular disease
Avoid adding DPP-4 inhibitors (inferior mortality/morbidity outcomes) 1
Lifestyle Modification Components
Physical Activity Protocol
Aerobic exercise:
- Minimum 150 minutes/week of moderate-intensity activity
- Sessions should last at least 10 minutes, aiming for 30 minutes daily
- No more than 2 days should elapse between exercise sessions 1
Resistance exercise:
- 2-3 sessions weekly on non-consecutive days
- At least one set of 5+ different exercises involving large muscle groups 1
Sedentary behavior:
- Break up prolonged sitting (≥30 minutes) with brief standing or walking 1
Nutrition Protocol
- Focus on foods high in fiber (vegetables, fruits, whole grains, legumes)
- Emphasize low-fat dairy products and fresh fish
- Limit high-energy foods rich in saturated fats and sweet desserts/snacks 1
- No specific diet has proven most effective, but weight reduction of 5-10% significantly improves glycemic control 2
Special Population Considerations
Children and Adolescents with T2DM
Initial therapy:
- If ketotic/DKA: Start insulin therapy
- If HbA1c ≥8.5%: Consider insulin therapy
- If HbA1c <8.5% without ketosis: Start metformin (titrate to 2,000 mg daily) 1
If glycemic goals not met:
- Consider adding GLP-1 receptor agonist approved for youth
- Consider insulin therapy (may exceed 1 unit/kg/day) 1
Monitoring:
- Regular blood glucose monitoring for those on insulin or medications with hypoglycemia risk
- Consider CGM for patients requiring frequent monitoring 1
Medication Management Pearls
When adding SGLT-2 inhibitors or GLP-1 agonists with adequate glycemic control, reduce or discontinue sulfonylureas or long-acting insulins to minimize hypoglycemia risk 1
For patients on insulin and planning exercise:
- May need additional carbohydrate intake if pre-exercise glucose <100 mg/dL
- Consider reducing insulin doses for planned exercise
- Be aware that intense activities may paradoxically raise blood glucose levels, especially if pre-exercise levels are elevated 1
Pioglitazone (thiazolidinedione class) should be taken once daily without regard to meals, starting at 15-30 mg and titrating up to 45 mg if needed 3
Common Pitfalls to Avoid
Failure to individualize HbA1c targets - Aim for 7-8% for most adults, but consider less stringent targets for patients with limited life expectancy, history of severe hypoglycemia, or advanced complications 1
Overlooking cardiovascular risk management - Type 2 diabetes management must include aggressive management of cardiovascular risk factors (hypertension, dyslipidemia) 4
Delaying intensification - Don't delay adding second-line agents when glycemic targets aren't met with metformin alone
Neglecting weight management - Weight loss of 5-10% can significantly improve insulin sensitivity and glycemic control 5
Focusing solely on medication - Lifestyle modifications are fundamental to diabetes management and should be emphasized at every visit, not just as initial therapy 1